These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3488021)

  • 1. Comparative activities of LY 164846 and other orally administered beta-lactam antibiotics against Haemophilus influenzae.
    Jorgensen JH; Redding JS; Howell AW
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1090-1. PubMed ID: 3488021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
    Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
    J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae?
    Billal DS; Hotomi M; Yamanaka N
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3463-4. PubMed ID: 17606681
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
    Doern GV; Brueggemann AB; Pierce G; Holley HP; Rauch A
    Antimicrob Agents Chemother; 1997 Feb; 41(2):292-7. PubMed ID: 9021182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
    Doern GV
    Diagn Microbiol Infect Dis; 1991; 14(1):75-7. PubMed ID: 1901536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
    Doern GV; Tubert TA
    Diagn Microbiol Infect Dis; 1990; 13(4):349-52. PubMed ID: 2127558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of loracarbef (LY163892), a new oral carbacephem antimicrobial agent, against respiratory isolates of Haemophilus influenzae and Moraxella catarrhalis.
    Doern GV; Vautour R; Parker D; Tubert T; Torres B
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1504-7. PubMed ID: 1929318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility of 206 Haemophilus influenzae isolates collected from children in central Italy.
    Zanchi A; Mencarelli M; Sansoni A; Rossolini A; Cellesi C
    Eur J Epidemiol; 1994 Dec; 10(6):699-702. PubMed ID: 7672050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative activities of moxalactam (LY 127935) a new semisynthetic 1-oxa-beta lactam antibiotic with 7 other antibiotics against type b Haemophilus influenzae.
    Chu ML; Harms JL; Liu C
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Sep; 14(3):146-55. PubMed ID: 6456875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activity of oral beta-lactam antibiotics at clinically achievable levels against Haemophilus influenzae serotype b.
    Doit C; Conort-Valentin S; Sanchez C; Mariani-Kurkdjian P; Bingen E
    J Antimicrob Chemother; 1994 Feb; 33(2):363-4. PubMed ID: 8182027
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity of ceftazidime (GR 20263) and other beta-lactam antibiotics against Haemophilus influenzae.
    Piot P; Van Dyck E; Colaert J
    Infection; 1983; 11 Suppl 1():S32-4. PubMed ID: 6339415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.
    Jones RN; Biedenbach DJ; Croco MA; Barrett MS
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):573-8. PubMed ID: 9764398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of ROB-1 beta-lactamase correlates with cefaclor resistance among recent isolates of Haemophilus influenzae.
    Karlowsky JA; Verma G; Zhanel GG; Hoban DJ
    J Antimicrob Chemother; 2000 Jun; 45(6):871-5. PubMed ID: 10837442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of clinically significant Haemophilus influenzae strains to oral antimicrobial agents used in Saudi Arabia.
    Shibl AM; Gaillot O
    Chemotherapy; 1994; 40(6):399-403. PubMed ID: 7842823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
    Torrico M; Aguilar L; González N; Giménez MJ; Echeverría O; Cafini F; Sevillano D; Alou L; Coronel P; Prieto J
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.
    Galán JC; Morosini MI; Baquero MR; Reig M; Baquero F
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2551-7. PubMed ID: 12878518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antimicrobial activity of piperacillin and seven other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase producing strains.
    Thornsberry C; Baker CN; Jones RN
    J Antimicrob Chemother; 1979 Mar; 5(2):137-42. PubMed ID: 107152
    [No Abstract]   [Full Text] [Related]  

  • 20. Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
    Alou L; Giménez MJ; Sevillano D; Aguilar L; González N; Echeverría O; Torrico M; Coronel P; Prieto J
    J Antimicrob Chemother; 2007 Apr; 59(4):652-7. PubMed ID: 17341471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.